Scott Seibel

Scientist IV at Boehringer Ingelheim

Role
Scientist Iv at Boehringer Ingelheim
Location
New Haven, CT, US
LinkedIn followers
500 followers

About Scott Seibel

Translational medicine scientist focusing on; the design, optimization, validation and implementation of assay systems supporting the discovery and development of antibodies targeting oncology related RTKs and biomarkers of disease activity/drug effect. Work utilizes cell culture, cell-based assays, FACS, ELISA, MSD and protein expression analysis. POC for out-sourcing in-vivo studies including; CRO selection, study design, supply acquisition and evaluation, study management and result reporting. Background knowledge and work experience in the areas of inflammation and microbial diseases. Strong interpersonal skills and experience in contributing to a cross functional, team-oriented environment in both large and small pharmaceutical company settings. Utilizes organizational, analytical and problem solving skills to ensure on time delivery of project goals. Effective oral and written communication of experimental designs, protocols, results and reports. Experienced Microsoft and Graphpad Prism user.

Experience

  1. Scientist Iv

    Boehringer Ingelheim

    Feb 2020 — Present · Ridgefield, CT, US

Education

  • Penn State University

    Bachelor, Biology

    1984 — 1989

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Scott Seibel — Scientist Iv at Boehringer Ingelheim in New Haven, CT, US | Unifers